Novo Nordisk Company Profile (SWX:NOVOB)

About Novo Nordisk (SWX:NOVOB)

Novo Nordisk logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: SWX:NOVOB
  • CUSIP: N/A
  • Web: N/A
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
 

Frequently Asked Questions for Novo Nordisk (SWX:NOVOB)

What is Novo Nordisk's stock symbol?

Novo Nordisk trades on the SWX under the ticker symbol "NOVOB."


MarketBeat Community Rating for Novo Nordisk (SWX NOVOB)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  61
MarketBeat's community ratings are surveys of what our community members think about Novo Nordisk and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Novo Nordisk (SWX:NOVOB) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating
Consensus Rating:Sell (Score: 1.00)
Consensus Price Target: N/A

Analysts' Ratings History for Novo Nordisk (SWX:NOVOB)
Show:
DateFirmActionRatingPrice TargetDetails
6/19/2017J P Morgan Chase & CoReiterated RatingSellView Rating Details
(Data available from 9/19/2015 forward)

Earnings

Earnings History for Novo Nordisk (SWX:NOVOB)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Novo Nordisk (SWX:NOVOB)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Novo Nordisk (SWX:NOVOB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Novo Nordisk (SWX:NOVOB)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Novo Nordisk (SWX:NOVOB)
Latest Headlines for Novo Nordisk (SWX:NOVOB)
Source:
DateHeadline
prnewswire.com logoInsurance whistleblower recoveries from Phillips & Cohen cases bring Novo Nordisk's Victoza settlement to $60 million
www.prnewswire.com - September 7 at 6:55 AM
globenewswire.com logoNovo Nordisk A/S: Share repurchase programme
globenewswire.com - September 4 at 7:54 PM
seekingalpha.com logoNovo Nordisk Offers Some Sweet Dividends With Its Strong Diabetes Portfolio
seekingalpha.com - September 2 at 6:50 AM
zacks.com logoNovo Nordisk's Victoza Gets FDA Nod for Label Expansion
www.zacks.com - August 29 at 5:57 AM
rttnews.com logoNovo Nordisk : Canada Oks Tresiba, New Basal Insulin For Type 1 And 2 Diabetes
www.rttnews.com - August 29 at 5:57 AM
streetinsider.com logoNovo Nordisk' (NVO) Says Victoza Approved in US as Type 2 Diabetes Treatment Indicated to Reduce Risk of Three Cardiovascular Events
www.streetinsider.com - August 27 at 2:56 AM
News IconFDA clears Novo Nordisk's diabetes drug to treat heart diseases
www.businessinsider.com - August 27 at 2:56 AM
seekingalpha.com logoNovo Nordisk's Next Crown Jewel
seekingalpha.com - August 21 at 11:37 PM
zacks.com logoNovo Nordisk's Semaglutide Shows Remarkable Results in Study
www.zacks.com - August 19 at 5:52 AM
seekingalpha.com logoNovo And Lilly Head For Diabetes Pricing Battle
seekingalpha.com - August 19 at 5:52 AM
streetinsider.com logoNovo Nordisk (NVO) Says Semaglutide Superior to Dulaglutide on Glucose Control and Weight Loss in People with Type 2 Diabetes in SUSTAIN 7
www.streetinsider.com - August 17 at 6:15 AM
cnbc.com logoEuropean markets lower; Vestas down 7%; Novo Nordisk up 2%
www.cnbc.com - August 17 at 6:15 AM
reuters.com logoRPT-UPDATE 1-Novo Nordisk's diabetes drug succeeds in key trial
www.reuters.com - August 17 at 6:15 AM
finance.yahoo.com logoNovo Ceo Is Looking at Targets in M&A ‘Hot Space’
finance.yahoo.com - August 11 at 6:56 AM
cnbc.com logoNovo Nordisk beats 2Q profit forecasts
www.cnbc.com - August 11 at 6:56 AM
nasdaq.com logoNovo Nordisk raises forecasts despite continued U.S. pressure
www.nasdaq.com - August 10 at 6:15 AM
msn.com logoNovo Nordisk's (NVO) CEO Lars Fruergaard Jorgensen on Q2 2017 Results - Earnings Call Transcript
www.msn.com - August 10 at 6:15 AM
seekingalpha.com logoNovo Nordisk: Growth Sends Its Shares Higher
seekingalpha.com - August 10 at 6:15 AM
reuters.com logoNovo Nordisk Q2 beats forecast; lifts outlook but sees lower U.S. prices in 2018
www.reuters.com - August 9 at 5:04 AM
cnbc.com logoEuropean stocks move lower on North Korea tensions; Brenntag down 5%
www.cnbc.com - August 9 at 5:04 AM
nasdaq.com logoNovo Nordisk sees lower U.S. prices in 2018, but lifts outlook after Q2
www.nasdaq.com - August 9 at 5:04 AM
marketwatch.com logoNovo Nordisk profit flat; upbeat on sales outlook
www.marketwatch.com - August 9 at 5:03 AM
nytimes.com logoEuropean Shares Fall on Paris Incident, North Korea Worries
www.nytimes.com - August 9 at 5:03 AM
reuters.com logoREFILE-BRIEF-Novo Nordisk says Victoza label update has been approved in EU
www.reuters.com - July 29 at 5:32 AM
zacks.com logoIs Novo Nordisk (NVO) Stock a Solid Choice Right Now?
www.zacks.com - July 22 at 7:01 AM
prnewswire.com logoNovo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management
www.prnewswire.com - July 12 at 2:30 PM
americanbankingnews.com logoJ P Morgan Chase & Co Reaffirms "Sell" Rating for Novo-Nordisk AS (NOVOB)
www.americanbankingnews.com - June 19 at 2:04 PM

Social

Social activity is not available for this stock.
This page was last updated on 9/19/2017 by MarketBeat.com Staff